Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose short-course oral olanzapine for perioperative anxiety in total joint arthroplasty
ChiCTR2400081238Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of olanzapine in anxiety disorder (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: State-Trait Anxiety Inventory-State score. Started Feb 2024; status: completed.
02
Drugs
olanzapine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2400081238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081238.